Nasaruplase

N/A

Report date: 2022/02/18 13:59:58
NME

Base Information

Drug NameNasaruplase
Drug Alias Name那沙普酶TomiezeThrombolyseGE-0943
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUrokinase plasminogen activator stimulants
TargetsUrokinase plasminogen activator
Therapy Area/IndicationsVenous ThrombosisMyocardial Infarction
Global Approved IndicationsVenous ThrombosisMyocardial Infarction
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1992/01/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesMitsubishi Pharma Corp
Inactive CompaniesN/A
Active IndicationsVenous ThrombosisMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeB01AD
Related LinksKEGG